| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 06/05/2001 | US6242575 Antibodies for detecting p27 protein |
| 06/05/2001 | US6242568 Zinc finger protein derivatives and methods therefor |
| 06/05/2001 | US6242469 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 06/05/2001 | US6242254 Cell has dna encoding tetracycline responsive transcriptional activator linked to tissue-specific promoter and tetracycline operator minimal promoter linked to dna encoding sv40 t antigen; cell proliferation is controlled by tetracycline |
| 06/05/2001 | US6242252 Hepatic progenitors and method of isolating same |
| 06/05/2001 | US6242249 Nucleotide sequences of trigger factor chaperones from staphylococcus; diagnosis; probes; primers; vaccines; bactericides; bacteriostats; antibodies; drug screening |
| 06/05/2001 | US6242247 Device for in vitro production includes space for receiving cells and culture medium and that has semipermeable or porous walls, and means for positioning and immersing cell space in culture medium; one wall is bone substitute plate |
| 06/05/2001 | US6242230 Process for microencapsulating cells |
| 06/05/2001 | US6242229 Topically applying composition including clarified and stabilized culture medium from non-photosynthetic filamentous bacterium to skin, scalp, or mucous membranes; reduces or delays aging of skin |
| 06/05/2001 | US6241988 Stable extract of hypericum perforatum L., a method for producing the same, and corresponding pharmaceutical preparations |
| 06/05/2001 | US6241981 Composition and method for repairing neurological tissue |
| 06/05/2001 | CA2030757C Agent for the storage and suspension of cells, especially erythrocytes |
| 06/05/2001 | CA2022650C Process for the preparation of a stable factor viii |
| 06/05/2001 | CA2018887C Red blood cell storage system |
| 06/05/2001 | CA1341246C Somatic cell gene therapy |
| 06/04/2001 | WO2001042474A2 Interferon-like molecules and uses thereof |
| 06/04/2001 | CA2395408A1 Interferon-like molecules and uses thereof |
| 05/31/2001 | WO2001038566A2 Screening method for candidate drugs |
| 05/31/2001 | WO2001038548A2 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors |
| 05/31/2001 | WO2001038495A2 Method for producing a thrombocyte preparation and a thrombocyte preparation |
| 05/31/2001 | WO2001038494A1 Method of proliferating natural killer cells |
| 05/31/2001 | WO2001038493A1 Treatment of human infertility |
| 05/31/2001 | WO2001038394A2 Polypetptides and methods for thymic vaccination |
| 05/31/2001 | WO2001038362A2 Production of vaccines |
| 05/31/2001 | WO2001038361A1 Modified adenovirus fibre and uses |
| 05/31/2001 | WO2001038339A1 Antimitotic compounds |
| 05/31/2001 | WO2001037884A2 Improved tissue engineered blood vessels and methods and apparatus for their manufacture |
| 05/31/2001 | WO2001037881A2 Gene therapy of hiv-positive patients by the expression of membrane-anchored gp41 peptides |
| 05/31/2001 | WO2001037880A1 Tablets comprising micro-organisms and method for preparation of the tablets |
| 05/31/2001 | WO2001037867A1 A new defective adenovirus and process for producing said adenovirus |
| 05/31/2001 | WO2001037866A1 A method of treating a malignancy in a subject and a pharmaceutical composition for use in same |
| 05/31/2001 | WO2001037865A1 Compositions and methods for treatment of allergic disorders |
| 05/31/2001 | WO2001037857A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | WO2001037847A2 Nontoxic vernix compositions and method of producing |
| 05/31/2001 | WO2001037671A1 Anti-angiogenic cellular agent for cancer therapy |
| 05/31/2001 | WO2001011030A3 Method and means for inducing cell-multiplication of non-active cells |
| 05/31/2001 | WO2001005411A8 Compositions addressing inflammation and/or degenerative disorders |
| 05/31/2001 | WO2000078931A3 Neuronal cell material, use of said material as a transplant and method for producing the same |
| 05/31/2001 | WO2000071140A3 Methods and compositions for modulating immune response and for the treatment of inflammatory disease |
| 05/31/2001 | WO2000070022A3 Ex vivo expansion of mammalian hematopoietic stem cells |
| 05/31/2001 | WO2000055345A3 Therapy of cancer by insect cells containing recombinant baculovirus encoding genes |
| 05/31/2001 | WO2000050072A3 Method for the purification, recovery, and sporulation of cysts and oocysts |
| 05/31/2001 | WO2000045853A3 Treatment of tumors with genetically engineered herpes virus |
| 05/31/2001 | WO2000010507A3 Use of melanin for inhibition of angiogenesis and macular degeneration |
| 05/31/2001 | WO1999035255A9 Compositions and methods for regulated secretion from neuroendocrine cell lines |
| 05/31/2001 | DE19959750C1 Production of skin implant, e.g. for treating burn or other open wound, uses flat element of fine biocompatible, biodegradable or bioresorbable fibers of hydrolytically condensed silicon compound on nutrient solution |
| 05/31/2001 | CA2422429A1 A method of treating a malignancy in a subject and a pharmaceutical composition for use in same |
| 05/31/2001 | CA2393322A1 Method of proliferating natural killer cells |
| 05/31/2001 | CA2392468A1 Gene therapy of hiv-positive patients by the expression of membrane-anchored gp41 peptides |
| 05/31/2001 | CA2392387A1 Polypeptides and methods for thymic vaccination |
| 05/31/2001 | CA2392366A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | CA2392272A1 Modified adenovirus fibre and uses |
| 05/31/2001 | CA2391499A1 Compositions and methods for treatment of allergic disorders |
| 05/31/2001 | CA2391434A1 Anti-angiogenic cellular agent for cancer therapy |
| 05/31/2001 | CA2390767A1 Nontoxic vernix compositions and method of producing |
| 05/31/2001 | CA2389667A1 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors |
| 05/30/2001 | EP1103615A1 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors |
| 05/30/2001 | EP1103610A1 Production of vaccines from immortalised mammalian cell lines |
| 05/30/2001 | EP1103562A1 Novel g-protein coupled receptor protein and dna thereof |
| 05/30/2001 | EP1103268A1 Use of staphylococcal enterotoxins or related compounds for cancer treatment by infusion |
| 05/30/2001 | EP1103190A1 Feed for prevention and/or treatment of coccidiosis |
| 05/30/2001 | EP1102862A1 Antisense oligonucleotides targeted to il-15 |
| 05/30/2001 | EP1102859A1 METHOD FOR OBTAINING FATTY ACIDS FROM BIOMASS BY COMBINED $i(IN-SITU) EXTRACTION, REACTION AND CHROMATOGRAPHY USING COMPRESSED GASES |
| 05/30/2001 | EP1102858A2 Cell lines for the propagation of mutated herpes viruses |
| 05/30/2001 | EP1102853A1 N-acetylglycosaminyltransferase genes |
| 05/30/2001 | EP1102851A1 Recombinant poliovirus for the treatment of cancer |
| 05/30/2001 | EP1102790A2 Immunological herpes simplex virus antigens and methods for use thereof |
| 05/30/2001 | EP1102595A2 Methods for increasing the solubility of nutritional materials using probiotic lactic acid-producing bacteria |
| 05/30/2001 | EP1102580A2 Formulations having probiotically active microorganisms |
| 05/30/2001 | EP1102531A1 Method and device for rearing insects, especially for obtaining a secretion from fly larvae for therapeutic application |
| 05/30/2001 | EP1032265A4 New psoralens for pathogen inactivation |
| 05/30/2001 | EP0951216A4 Method for conversion of blood type |
| 05/30/2001 | EP0925067A4 Composition and method for repairing neurological tissue |
| 05/30/2001 | CN1297531A Isolated nucleic acid molecule encoding cancer associated antigens, antigens per se, and uses thereof |
| 05/30/2001 | CN1297486A Anti-viral vectors |
| 05/30/2001 | CN1297479A Modified adenovirus contg. fiber replacement protein |
| 05/30/2001 | CN1297478A Compositions comprising viruses and methods for concentrating virus preparations |
| 05/30/2001 | CN1297380A Continuous magnetic separation of components from mixture |
| 05/30/2001 | CN1297040A Process for preparing Mg-enriched spirulina |
| 05/30/2001 | CN1296839A Process and formulation for preparing bezoar mux vomica powder medicine 'Kuangquanling' and its product |
| 05/30/2001 | CN1296837A Chinese patent medicine for treating peptide ulcer |
| 05/30/2001 | CN1296830A Chinese-medicinal capsule for treating diabetes |
| 05/30/2001 | CN1296829A Quickly thrombus dissolving tablet |
| 05/30/2001 | CN1296827A Quick-acting bone-setting powder medicine |
| 05/30/2001 | CN1296826A Medicine for treating mastopathy |
| 05/30/2001 | CN1296825A Capsule or tablet for treating viral hepatitis |
| 05/30/2001 | CN1296824A Weishukang for treating gastrosis |
| 05/30/2001 | CN1296823A Antineoplastic Chinese medicine and its preparing process |
| 05/30/2001 | CN1296820A Gansu julid tablet for gastrosis and its preparing process |
| 05/30/2001 | CN1066344C Multi-effect oral liquor for bringing down fever |
| 05/30/2001 | CN1066337C Drug for curing rheumatic arthritis and rheumatoid arthritis |
| 05/30/2001 | CN1066334C Medicines for treating bone tuberculosis, osteomyelitis and other swelling pain |
| 05/30/2001 | CN1066331C Oral medicinal liquor prepared from Armilariella tabescens |
| 05/30/2001 | CN1066330C Bear bile products and preparation process |
| 05/30/2001 | CN1066318C Blood enriching food |
| 05/29/2001 | US6239256 Isolated muteins of proteins SCP-1, and compositions containing the mutein |
| 05/29/2001 | US6238914 Nucleic acid |
| 05/29/2001 | US6238893 Method for intracellular DNA amplification |
| 05/29/2001 | US6238663 Irradiating with light |
| 05/29/2001 | US6238660 Interleukin-12 inducer and medical composition |